GB9913782D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB9913782D0 GB9913782D0 GBGB9913782.0A GB9913782A GB9913782D0 GB 9913782 D0 GB9913782 D0 GB 9913782D0 GB 9913782 A GB9913782 A GB 9913782A GB 9913782 D0 GB9913782 D0 GB 9913782D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9913782.0A GB9913782D0 (en) | 1999-06-14 | 1999-06-14 | Novel compounds |
| PCT/GB2000/002330 WO2000076488A2 (en) | 1999-06-14 | 2000-06-14 | Use of a ppar agonist for treating type 1 diabetes |
| AU55470/00A AU5547000A (en) | 1999-06-14 | 2000-06-14 | Novel treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9913782.0A GB9913782D0 (en) | 1999-06-14 | 1999-06-14 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9913782D0 true GB9913782D0 (en) | 1999-08-11 |
Family
ID=10855294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9913782.0A Ceased GB9913782D0 (en) | 1999-06-14 | 1999-06-14 | Novel compounds |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU5547000A (en) |
| GB (1) | GB9913782D0 (en) |
| WO (1) | WO2000076488A2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001272098A1 (en) * | 2000-03-09 | 2001-09-17 | Sanofi-Aventis Deutschland Gmbh | Therapeutic uses of PPAR mediators |
| EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2624828T3 (en) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others |
| WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| AU2014274812B2 (en) | 2013-06-05 | 2018-09-27 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10199003I1 (en) * | 1987-09-04 | 2003-06-12 | Beecham Group Plc | Substituted thiazolidine ion derivatives |
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| WO1997043283A1 (en) * | 1996-05-16 | 1997-11-20 | Boehringer Mannheim Gmbh | New process for preparing troglitazone |
| EP0953355A4 (en) * | 1996-05-31 | 2002-02-27 | Sankyo Co | Remedy for autoimmune diseases |
| GB9908647D0 (en) * | 1999-04-15 | 1999-06-09 | Smithkline Beecham Plc | Novel compounds |
-
1999
- 1999-06-14 GB GBGB9913782.0A patent/GB9913782D0/en not_active Ceased
-
2000
- 2000-06-14 WO PCT/GB2000/002330 patent/WO2000076488A2/en active Application Filing
- 2000-06-14 AU AU55470/00A patent/AU5547000A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000076488A2 (en) | 2000-12-21 |
| WO2000076488A3 (en) | 2001-05-10 |
| AU5547000A (en) | 2001-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1140083A4 (en) | Novel compounds | |
| GB9902084D0 (en) | Novel compounds | |
| GB9913782D0 (en) | Novel compounds | |
| GB9902697D0 (en) | Novel compounds | |
| EG24063A (en) | Novel compounds | |
| GB9901256D0 (en) | Novel compounds | |
| GB9902937D0 (en) | Novel compounds | |
| GB9902070D0 (en) | Novel compounds | |
| GB9902880D0 (en) | Novel compounds | |
| GB9902090D0 (en) | Novel compounds | |
| GB9902088D0 (en) | Novel compounds | |
| GB9903278D0 (en) | Novel compounds | |
| GB9903414D0 (en) | Novel compounds | |
| GB9902936D0 (en) | Novel compounds | |
| GB9903416D0 (en) | Novel compounds | |
| GB9902879D0 (en) | Novel compounds | |
| GB9903417D0 (en) | Novel compounds | |
| GB9902657D0 (en) | Novel compounds | |
| GB9902169D0 (en) | Novel compounds | |
| GB9902168D0 (en) | Novel compounds | |
| GB9902166D0 (en) | Novel compounds | |
| GB9902165D0 (en) | Novel compounds | |
| GB9902164D0 (en) | Novel compounds | |
| GB9902163D0 (en) | Novel compounds | |
| GB9902078D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |